Your browser doesn't support javascript.
loading
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
Weinstock-Guttman, Bianca; Hagemeier, Jesper; Kavak, Katelyn S; Saini, Vasu; Patrick, Kara; Ramasamy, Deepa P; Nadeem, Muhammad; Carl, Ellen; Hojnacki, David; Zivadinov, Robert.
Afiliación
  • Weinstock-Guttman B; Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA Department of Neurology, State University of New York at Buffalo, Buffalo, New York, USA.
  • Hagemeier J; Department of Neurology, Buffalo Neuroimaging Analysis Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
  • Kavak KS; Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA.
  • Saini V; Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA.
  • Patrick K; Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA.
  • Ramasamy DP; Department of Neurology, Buffalo Neuroimaging Analysis Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
  • Nadeem M; Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA.
  • Carl E; Department of Neurology, Buffalo Neuroimaging Analysis Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
  • Hojnacki D; Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA.
  • Zivadinov R; Department of Neurology, State University of New York at Buffalo, Buffalo, New York, USA Department of Neurology, Buffalo Neuroimaging Analysis Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA MR Imaging Clinical Translat
J Neurol Neurosurg Psychiatry ; 87(9): 937-43, 2016 Sep.
Article en En | MEDLINE | ID: mdl-26780938
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Recurrencia / Esclerosis Múltiple Recurrente-Remitente / Natalizumab Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Recurrencia / Esclerosis Múltiple Recurrente-Remitente / Natalizumab Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos